Back to 
Fuller & Thaler Asset Management, Inc.
Fuller & Thaler Asset Management, Inc.
LGND
Showing 0 of 2 quarters
Position history for Fuller & Thaler Asset Management, Inc.'s holdings in Ligand Pharmaceuticals Incorporated
No. Fuller & Thaler Asset Management exited its LGND (Ligand Pharmaceuticals) position in Q1 2019. Its Q4 2018 13F listed 44,640 shares worth $6.1M. Fuller & Thaler Asset Management already held LGND in its Q4 2018 13F, the earliest on record, and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.